Enose - Derived Response Clusters in Severe Asthmatics Treated With Anti-IL5/5R Biologics

被引：0
|
作者：
Dixey, P. [1 ]
Kermani, N. Zounemat [2 ]
Raby, K. [1 ]
Bhavsar, P. K. [1 ]
Chung, K. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Imperial Coll London, Data Sci Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3013
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CHANGE IN FENO AS A BIOMARKER OF RESPONSE TO ANTI-IL5/5R THERAPIES IN SEVERE ASTHMA
    Hearn, A. P.
    Kavanagh, J. E.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A80 - A80
  • [2] THE RELATIONSHIP BETWEEN FENO AND RESPONSE TO ANTI-IL5/5R BIOLOGIC THERAPIES IN SEVERE EOSINOPHILIC ASTHMA
    Hearn, A. P.
    Kavanagh, J.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A143 - A144
  • [3] EFFECTIVENESS OF ANTI-IL4R THERAPY FOLLOWING SUBOPTIMAL RESPONSE TO ANTI-IL5/5R THERAPY IN SEVERE EOSINOPHILIC ASTHMA
    Mason, T. W.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Roxas, C.
    Green, L.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A177 - A178
  • [4] Effectiveness of Anti-IL4R Therapy Following Suboptimal Response to Anti-IL5/5R Therapy in Severe Eosinophilic Asthma
    Mason, T.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Cetin, Gulden Pacaci
    Arslan, Bahar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1935 - 1936
  • [6] Heterogeneous ILC responses in severe asthma patients undergoing anti-IL5/5Rα therapy
    Mincham, Kyle
    Loewenthal, Lola
    Meyer, Garance
    Marfia, Martina
    Martin, Minerva Garcia
    Patel, Pujan
    Lloyd, Clare
    Snelgrove, Robert
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 19 - 19
  • [7] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [8] Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics
    Lorente-Sorolla, C.
    Bernaola, J.
    Sanchez-Mellado, D.
    Gil-Martinez, M.
    Naharro-Gonzalez, S.
    Betancor, D.
    Fernandez-Nieto, M.
    Pinillos-Robles, E. J.
    Santillan Coello, J. M.
    Villacampa-Auba, J. M.
    Rodriguez-Nieto, M. J.
    Sastre, J.
    Valverde-Monge, M.
    Rodrigo-Munoz, J. M.
    del Pozo, V.
    ALLERGY, 2023, 78 (11) : 3027 - 3031
  • [9] Long-term effectiveness of anti-IL4R therapy following suboptimal response to anti-IL5/5R therapy in severe eosinophilic asthma
    Gates, J.
    Fernandes, M.
    Hearn, A.
    Green, L.
    Thomson, L.
    Roxas, C.
    Lam, J.
    d'Ancona, G.
    Nanzer, A. M.
    Dhariwal, J.
    Jackson, D. J.
    THORAX, 2023, 78 (SUPPL_4) : A47 - A48
  • [10] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345